Evidence map›Paper›PMID 36994106›Full record

ArticleFrontiers in cell and developmental biology2023

Sustained IP3-linked Ca

Riccardo Filadi, Agnese De Mario, Matteo Audano, Patrizia Romani, Silvia Pedretti, Cesar Cardenas, Sirio Dupont, Cristina Mammucari, Nico Mitro, Paola Pizzo

Open access · goldFull text read
In one paragraph

Article in Frontiers in cell and developmental biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. The ubiquitin-activating enzyme inhibitor TAK-243 activates store-operated CaBiochimica et biophysica acta. Molecular cell research · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Dysregulation of Mitochondrial Function in Cancer Cells.International journal of molecular sciences · 2025
    Review
  7. The IPBiochimica et biophysica acta. Molecular basis of disease · 2025
    Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Riccardo FiladiNeuroscience Institute, National Research Council (CNR), Padua, Italy.
Agnese De MarioDepartment of Biomedical Sciences, University of Padova, Padua, Italy.
Matteo AudanoDepartment of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
Patrizia RomaniDepartment of Molecular Medicine (DMM), University of Padova, Padua, Italy.
Silvia PedrettiDepartment of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
Cesar CardenasFaculty of Sciences, Universidad Mayor, Center for Integrative Biology, Santiago, Chile.
Sirio DupontDepartment of Molecular Medicine (DMM), University of Padova, Padua, Italy.
Cristina MammucariDepartment of Biomedical Sciences, University of Padova, Padua, Italy.
Nico MitroDepartment of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
Paola PizzoNeuroscience Institute, National Research Council (CNR), Padua, Italy.
University of Padua · ITUniversity of Milan · ITUniversidad Mayor · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rewiring of mitochondrial metabolism has been described in different cancers as a key step for their progression. Calcium (Ca

Indexed as

acylcarnitinebreast cancerCa2+fatty acidsIP3MCUmitochondriaTNBC

Identifiers

PMID36994106
PMCPMC10040683
OpenAlexW4324087511

What Socratic holds

Textfull text, public
LicenceCC BY
measurements read80
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.